(News Bulletin 247) – Johnson & Johnson has announced its results for the first quarter of 2023.
Sales grew 5.6% to $24.7 billion in the first quarter of 2023. Operating growth was 9.0% and adjusted operating growth was 7.6%.
The group posted a result down 101.3% compared to the 1st quarter of 2022 due to a special one-off charge. Adjusted earnings per share (EPS) was $2.68, up 0.4%.
The group is increasing the full-year 2023 guidance midpoints for adjusted operating sales and adjusted operating EPS.
“Our first quarter results demonstrate strong performance across all three segments of our business and reflect the dedication of Johnson & Johnson colleagues around the world,” said Joaquin Duato, Chairman of the Board.
“With this momentum, I look forward to the rest of the year, a year filled with exciting catalysts that will create short and long-term value for patients and all of our stakeholders. ‘
Copyright (c) 2023 News Bulletin 247. All rights reserved.
I have over 8 years of experience working in the news industry. I have worked as a reporter, editor, and now managing editor at 247 News Agency. I am responsible for the day-to-day operations of the news website and overseeing all of the content that is published. I also write a column for the website, covering mostly market news.
